Wen Fan

Wen Fan


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2024 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
PTPeng-Peng Tian
Peng-Peng Tian
SSShan-Shan Su
Shan-Shan Su
LZLi-Sha Zhu
Li-Sha Zhu
TWTian Wang
Tian Wang
HYHui Yang
Hui Yang
HYHua-Wei Yi
Hua-Wei Yi
Background: Early and appropriate antibiotic treatment improves the clinical outcome of patients with sepsis. There is an urgent need for rapid identification (ID) and antimicrobial susceptibility testing (AST) of bacteria that cause bloodstream infection (BSI). Rapid ID and AST can be achieved by short-term incubation on solid medium of positive blood cultures using MALDI-TOF mass spectrometry (MS) and the BD M50 system. The purpose of this study is to evaluate the performance of rapid method compared to traditional method. Methods: A total of 124 mono-microbial samples were collected. Positive blood culture samples were short-term incubated on blood agar plates and chocolate agar plates for 5 ∼ 7 h, and the rapid ID and AST were achieved through Zybio EXS2000 MS and BD M50 System, respectively. Results: Compared with the traditional 24 h culture for ID, this rapid method can shorten the cultivation time to 5 ∼ 7 h. Accurate organism ID was achieved in 90.6% of Gram-positive bacteria (GP), 98.5% of Gram-negative bacteria (GN), and 100% of fungi. The AST resulted in the 98.5% essential agreement (EA) and 97.1% category agreements (CA) in NMIC-413, 99.4% EA and 98.9% CA in PMIC-92, 100% both EA and CA in SMIC-2. Besides, this method can be used for 67.2% (264/393) of culture bottles during routine work. The mean turn-around time (TAT) for obtaining final results by conventional method is approximately 72.6 ± 10.5 h, which is nearly 24 h longer than the rapid method. Conclusions: The newly described method is expected to provide faster and reliable ID and AST results, making it an important tool for rapid management of blood cultures (BCs). In addition, this rapid method can be used to process most positive blood cultures, enabling patients to receive rapid and effective treatment.

1 July 2023 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
YWYuyan Wang
Yuyan Wang
HDHaibo Dong
Haibo Dong
TDTengyun Dong
Tengyun Dong
LZLulu Zhao
Lulu Zhao
WFWen Fan
Wen Fan
WYWeiqi Yao
Weiqi Yao

8 January 2024 in Frontiers in Microbiology
Verified
Journal Article
Open access
HYHua-Wei Yi
Hua-Wei Yi
XWXian-Mo Wang
Xian-Mo Wang
XTXin Tan
Xin Tan
CDCai-Zhi Ding
Cai-Zhi Ding
CZChang-Li Zhang
Chang-Li Zhang
WFWen Fan
Wen Fan
Background: There are many similarities in the clinical manifestations of human norovirus and SARS-CoV-2 infections, and nucleic acid detection is the gold standard for diagnosing both diseases. In order to expedite the identification of norovirus and SARS-CoV-2, a quantitative one-step triplex reverse transcription PCR (RT-qPCR) method was designed in this paper.Methods: A one-step triplex RT-qPCR assay was developed for simultaneous detection and differentiation of human norovirus GI (NoV-GI), GII (NoV-GII) and SARS-CoV-2 from fecal specimens.Results: The triplex RT-qPCR assay had high detection reproducibility (CV < 1%) and sensitivity. The lower limits of detection (LLOD95) of the triplex RT-qPCR assay for each target site were 128.5–172.8 copies/mL, and LLOD95 of the singleplex RT-qPCR assay were 110.3–142.0 copies/mL. Meanwhile, among the detection of clinical oropharyngeal swabs and fecal specimens, the results of the singleplex and triplex RT-qPCR assay showed high agreement.Conclusion: The triplex RT-qPCR assay for simultaneous detection of NoV-GI, NoV-GII and SARS-CoV-2 from fecal specimens has high clinical application value.

15 July 2025 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Open access
MCMeng-Yang Cai
Meng-Yang Cai
HYHua-Wei Yi
Hua-Wei Yi
YCYa-Qian Cai
Ya-Qian Cai
RFRui-Min Feng
Rui-Min Feng
YLYe Liu
Ye Liu
XWXian-Mo Wang
Xian-Mo Wang
Acute respiratory infections (ARIs) are a leading cause of pediatric morbidity and mortality globally, yet comprehensive pathogen epidemiology in children remains understudied. This study aimed to characterize the pathogen profiles, co-infection patterns, and epidemiological trends of pediatric ARIs in Xiantao, China, using targeted next-generation sequencing (tNGS). A retrospective analysis was conducted on 4,330 children hospitalized with ARIs from May 2022 to September 2023. Oropharyngeal swab specimens were tested by tNGS for 96 pathogens via ultra-multiplex PCR and high-throughput sequencing. Pathogens were detected in 99.3 % (4,298/4,330) of cases, with multi-pathogen co-infections in 88.7 % (3811/4298) of samples, including dual (26.1 %), triple (28.2 %), and ≥quadruple pathogens (34.4 %), demonstrating high co-infection complexity. Bacterial pathogens (57.7 %) exceeded viral (35.7 %) and Mycoplasma/ Chlamydial (6.6 %). Age-stratified analysis revealed significant variability in 37 pathogens (p < 0.05), with incidence inversely correlated to age. Seasonal peaks occurred in spring (March-May) and early summer (June), driven first by bacterial then viral agents. Pneumonia (57.8 %, 2,407/4,162) and acute upper respiratory infections (24.1 %, 1,005/4,162) were the most frequent clinical diagnoses. tNGS provides rapid, comprehensive pathogen identification in pediatric ARIs while uncovering intricate co-infection patterns. The findings highlight the importance of age-specific and seasonal considerations in managing respiratory infections, and suggest that tNGS has the potential to provide information useful for clinical decision-making, reduce antibiotic misuse, and improve pediatric outcomes-although these advantages await confirmation in future studies.